Uguz, Faruk2024-02-232024-02-2320150890-33441552-5732https://doi.org/10.1177/0890334415582207https://hdl.handle.net/20.500.12452/14398Depression and anxiety disorders are frequently seen in the postpartum period. Primary pharmacological agents for these disorders are antidepressants, especially selective serotonin reuptake inhibitors. Despite no adverse reports, data on safety for the maternal use of fluvoxamine on breastfed infants are limited. This case report presents diarrhea and vomiting in the breastfed baby of a woman using fluvoxamine at 50 mg/d.eninfo:eu-repo/semantics/closedAccessAntidepressantsBreastfeedingPostnatal DepressionPostpartum DepressionArticle313371373258964692-s2.0-84937580629Q1WOS:000358070300008Q110.1177/0890334415582207